MedPage Today) — The use of dupilumab (Dupixent) for the treatment of atopic dermatitis was associated with an increased risk of psoriasis compared with other systemic agents, according to a retrospective cohort study.
Among over 19,000 matched…
Dupilumab for Atopic Dermatitis Linked to Increased Risk of Psoriasis

Leave a Comment Leave a Comment